*** CHEMICAL IDENTIFICATION ***
RTECS NUMBER : UK7930000
CHEMICAL NAME : Prosta-5,13-dien-1-oic acid, 9,15-dihydroxy-11-oxo-,
(5Z,9-alpha,13E,15S)-
CAS REGISTRY NUMBER : 41598-07-6
BEILSTEIN REFERENCE NO. : 2170623
LAST UPDATED : 199612
DATA ITEMS CITED : 5
MOLECULAR FORMULA : C20-H32-O5
MOLECULAR WEIGHT : 352.52
WISWESSER LINE NOTATION : T5VTJ B1U7 C2U4VQ DQ
COMPOUND DESCRIPTOR : Mutagen
Reproductive Effector
SYNONYMS/TRADE NAMES :
* 11-Dehydroprostaglandin F2-alpha
* PGD2
* Prostaglandin D2
*** HEALTH HAZARD DATA ***
** REPRODUCTIVE DATA **
TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Subcutaneous
SPECIES OBSERVED : Rodent - hamster
DOSE : 400 ug/kg
SEX/DURATION : female 4 day(s) after conception
TOXIC EFFECTS :
Reproductive - Fertility - female fertility index (e.g. # females pregnant
per # sperm positive females; # females pregnant per # females mated)
REFERENCE :
JMCMAR Journal of Medicinal Chemistry. (American Chemical Soc.,
Distribution Office Dept. 223, POB POB 57136, West End Stn., Washington, DC
20037) V.6- 1963- Volume(issue)/page/year: 26,790,1983
** MUTATION DATA **
TYPE OF TEST : DNA inhibition
TEST SYSTEM : Human Ascites tumor
DOSE/DURATION : 2 mg/L
REFERENCE :
CNREA8 Cancer Research. (Public Ledger Building, Suit 816, 6th & Chestnut
Sts., Philadelphia, PA 19106) V.1- 1941- Volume(issue)/page/year:
46,3364,1986
TYPE OF TEST : Mutation test systems - not otherwise specified
TEST SYSTEM : Human Ascites tumor
DOSE/DURATION : 1 mg/L
REFERENCE :
CNREA8 Cancer Research. (Public Ledger Building, Suit 816, 6th & Chestnut
Sts., Philadelphia, PA 19106) V.1- 1941- Volume(issue)/page/year:
46,3364,1986
TYPE OF TEST : DNA inhibition
TEST SYSTEM : Rodent - mouse Cells - not otherwise specified
DOSE/DURATION : 5 mg/L/24H
REFERENCE :
CNREA8 Cancer Research. (Public Ledger Building, Suit 816, 6th & Chestnut
Sts., Philadelphia, PA 19106) V.1- 1941- Volume(issue)/page/year:
46,1688,1986
TYPE OF TEST : Mutation test systems - not otherwise specified
TEST SYSTEM : Rodent - mouse Cells - not otherwise specified
DOSE/DURATION : 5 mg/L/24H
REFERENCE :
CNREA8 Cancer Research. (Public Ledger Building, Suit 816, 6th & Chestnut
Sts., Philadelphia, PA 19106) V.1- 1941- Volume(issue)/page/year:
46,1688,1986
*** END OF RECORD ***